Fig. 2
Boxplot of pretreatment ALC levels in each response group. Patients achieving CR and VGPR had higher ALC levels than those achieving PR, and patients achieving PR also had higher ALC levels than those achieving SD (p = 0.021, p = 0.022, respectively). VD = Bortezomib-dexamethasone.